Dr Richard Mollard is the Chief Scientific Officer of PharmAust Limited and the Chief Executive Officer of subsidiary company Pitney Pharmaceuticals Pty Limited.
Dr Mollard received a PhD in 1996 from Monash University and an MBA in 2006 from Melbourne Business School in conjunction with the University of St Gallen, Switzerland. Dr Mollard has held scientific positions in France, the US and Australia working with: University Louis Pasteur/ IGBMC/ Bristol Myers Squibb, University of Michigan/ Eli Lilly & Co and Monash University. Dr Mollard has further previously consulted in business development and technical diligence for ASX listed companies such as Agenix Ltd, Immuron Ltd, PharmAust Ltd, and Regeneus Ltd as well as being founder, executive and consultant with biotech startup companies working in Australia, China, Hong Kong, Japan, Malaysia, Vietnam, Thailand and Singapore.
Dr Mollard is the author of over 30 peer-reviewed and invited scientific journal publications and has assisted in raising over AUD 100 million in capital. He currently holds the position of Honorary Fellow with the Department of Veterinary Sciences and Agriculture at the University of Melbourne.